The Coronary Patient Learning Objectives

Slides:



Advertisements
Similar presentations
patients, 51 countries, 1139 centers Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Rationale, design, and baseline characteristics of.
Advertisements

The role of the RST in emergency response Session 6 Presentation 2.
CARDIAC SURGERY QUESTION #1 Studies comparing CABG vs PTCA have shown that: A) CABG is better B) PTCA is better C) CABG involves more perioperative risk.
Innovative Minimally Invasive Circulatory Assist Device.
ARTS I & II Keith D Dawkins Southampton University Hospital.
METHODS Articles used included randomized controlled clinical trials of adults ranging from 50 to 75 years of age who had undergone either angioplasty.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
New ESC/EACTS guidelines on myocardial revascularisation Indications for coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention.
Introduction Training on Safe Hospitals in Disasters.
Surgical approach of aortic valve disease associated with coronary artery disease Al Hussein Hussam Cernica D.R., Al Hussein S.M., Bud I.T., Ceteras D.M.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
The association between serum CRP, total cholesterol, triglycerides and coronary artery disease Beata Virginas, Timea Gal.
Trial Design Issues Associated with Evaluation of Distal Protection Devices in Diseased Saphenous Vein Grafts Bram D. Zuckerman, MD, FACC Medical Officer,
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography.
Unnecessary Lipid Screening of Inpatient Admissions Dennis Whang 4/2/12 DSR2.
Peter K. Smith, MD, Robert M. Califf, MD, Robert H
From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.
Conditions & Treatments Conditions Treatments Our experts cardiologist diagnose and treat patients with coronary artery disease, heart failure, valve.
The Aortic Valve Patient Learning Objectives
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
The Patient Experience With Systemic Lupus Erythematosus
Team 1: 32 responses Team 2: 55 responses Team 3: 29 responses
HOOPS FOR HEART HEALTHY HEART STAY FIT NOW
Dual Goals for the Management of Stable Ischemic Heart Disease (SIHD)
New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery  Stephen.
Battling Constipation
Jun M, et al. Lancet 2010 Epub May 10
Nat. Rev. Cardiol. doi: /nrcardio
The Mitral Valve Patient Learning Objectives
The surgical and interventional hybrid era: Experiences from China
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
MACE rate among CAD severity groups (total 0
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
CAD and HF Often Coexist
EGPA.
Coronary revascularisation rate (total 5
The role of the RST in emergency response
Robotic-Assisted Coronary Artery Bypass on a Beating Heart: Initial Experience and Implications for the Future  William F. Turner, MD, John H. Sloan,
Antithrombotic Therapy in Vascular Protection: From CAD to HF
The recommended approach to patients with chronic obstructive pulmonary disease (COPD) presenting with dyspnoea. The recommended approach to patients with.
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
The Heart and Circulatory System
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The role of the RST in emergency response
Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years 
Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.
Peter K. Smith, MD, Robert M. Califf, MD, Robert H
(A) Meta-analysis of repeat revascularisation in randomised trials.
Hybrid Coronary Revascularization by Endoscopic Robotic Coronary Artery Bypass Grafting on Beating Heart and Stent Placement  Changqing Gao, MD, Ming.
The role of the RST in emergency response
Markov model scheme. Markov model scheme. Patients start (state 0) with uncomplicated PCI revascularisation; then cycle between health states until death.
Kaplan–Meier survival curve for major adverse cardiac events (MACE): a trend towards superior survival in patients without signs of coronary artery disease.
Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.
Characteristics of included studies
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Glenn N. Levine et al. JACC 2011;58:e44-e122
Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Davide Capodanno et al. JCIN 2009;2:
Summary of STICH trial patients included in the analysis of 6 min walk distance. Reasons for non-inclusion at each follow-up time are given. CABG, coronary.
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization  Philippe Kolh, MD, PhD, Paul Kurlansky,
The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization  Lorenzo Azzalini,
Event Details 09:00 – Welcome Address / Coffee
FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.
Off-Pump, In Situ Internal Thoracic Artery Grafting: A Durable Treatment for Single- Vessel Coronary Artery Disease  Kerem M. Vural, MD, Zafer H. Iscan,
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

The Coronary Patient Learning Objectives Assess systematic heart team approach for management of high risk ACS in an emergency setting. Analyze and review the role of support devices in the management of high risk ACS. Review the hybrid robotic technique for arterial revascularisation and methods for coordinating it with percutaneous revascularisation.

The Coronary Patient 8h00 – 8h15 Related Heart Team Concept 2016 Case Presentation 8h20 – 9h00 Heart Team Discussion 9h00 – 10h00 Live Cases 10h00 – 10h25 COFFEE BREAK 10h25 – 10h40 State of the art Assessment of CAD 10h40 – 11h10 State-of-the-art Percutaneous Revascularization 11h10 – 11h40 State-of-the-art Surgical Revascularization 11h40 – 11h45 Summary and Concluding Remarks 11h45 – 13h45 Workshops - Working Luncheon * - Hotel Nelligan